Numbers of effector (CD3+CD4-CD45RA+CD27-CD197-) CD8+ T cells remained expanded over the course of COVID-19 recovery and counts were significantly greater than healthy controls at ten-week follow-up (Figure 3G). This evidence concerns the gene CD4 and COVID-19.